Lixte Biotechnology Holdings Inc Warrants (01/01/2025) LIXTW 深 滬
等待開盤 03-26 09:30:00 美东时间
0.0221
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0221
- 總市值 29.92万
- 52周最高 0.38
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.01
- 委 比 0.00%
- 總股本 1353.83万
- 歷史最高 6.77
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lixte Amends Share Exchange, Clarifies Liora Ownership Structure
Lixte Biotechnology Holdings ( ($LIXT) ) just unveiled an update. On March 6, 2...
03-11 04:43
Powell Max Limited Successfully Repositions for Its Next Phase of Growth
Powell Max Limited announced key updates, including raising $17 million, appointing Geordan Pursglove as CEO, reconstituting the Board, and regaining Nasdaq compliance. The company completed restructuring by end-February and thanked Spartan Capital Securities and investors for support.
03-09 12:30
Lixte Elevates Liora Leadership to Advance Proton Therapy
An update from Lixte Biotechnology Holdings ( ($LIXT) ) is now available. On Fe...
02-18 22:00
Lixte Subsidiary Liora Technologies Europe Names Sidney Braun CEO
Lixte Subsidiary Liora Technologies Europe Names Sidney Braun CEO Lixte Biotechnology Holdings Inc. appointed healthcare industry veteran Sidney Braun as CEO of its Liora Technologies Europe Ltd. subsidiary. Liora is developing electronically controlled proton therapy systems, including its LiGHT Sy
02-18 21:04
BRIEF-Lixte Biotechnology Holdings Expands Collaboration With University Of Texas MD Anderson Cancer Center & GSK For Lb-100
Dec 23 (Reuters) - GSK plc GSK.L: LIXTE BIOTECHNOLOGY HOLDINGS INC - EXPANDS COLLABORATION WITH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER & GSK FOR LB-100 Source text: ID:nGNX3DR1np Further compan...
2025-12-23 21:17
Lixte Biotechnology Announces New Registered Direct Offering
Lixte Biotechnology Holdings ( ($LIXT) ) has shared an announcement. On Decembe...
2025-12-23 06:48
BRIEF-Lixte Biotechnology Raises $4.3M in Market‑Priced Registered Direct Offering
Dec 18 (Reuters) - Lixte Biotechnology Holdings Inc LIXT.O: LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES $4.3 MILLION REGISTERED DIRECT OFFERING PRICED AT THE MARKET UNDER NASDAQ RULES Source text: ID...
2025-12-18 22:41
Lixte Biotechnology Commences $4.3M Common Stock, Pre-Funded Offering At $4.09/Common Unit
Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the "Company"), a biotech company focused on advancing cancer treatments, today announced that it has entered into definitive agreements in a registered direct offering
2025-12-18 22:11
Lixte Biotechnology Holds Annual Meeting, Approves Key Issues
The latest update is out from Lixte Biotechnology Holdings ( ($LIXT) ). On Dece...
2025-12-12 04:17
Lixte Biotechnology Holdings Inc. held annual shareholder meeting
Lixte Biotechnology Holdings Inc. held its Annual Meeting on December 8, 2025. Shareholders approved the election of Geordan Pursglove, Jason Sawyer, Dr. Michael Holloway, Lourdes Felix, and Guy Primu...
2025-12-12 03:52
